AC
TECH icon

Allstate Corporation’s Bio-Techne TECH Stock Holding History

Allstate Corporation’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$491K Buy
6,947
+393
+6% +$21.2K ﹤0.01% 1042
2026
Q1 		$343K Buy
+6,554
New +$393K ﹤0.01% 1064
2025
Q1 		– Sell
-4,639
Closed -$334K – 644
2024
Q4 		$334K Buy
+4,639
New +$341K 0.01% 563
2023
Q1 		– Sell
-7,860
Closed -$651K – 516
2022
Q4 		$651K Buy
7,860
+352
+5% +$28K 0.02% 444
2022
Q3 		$533K Buy
7,508
+772
+11% +$66.7K 0.02% 480
2022
Q2 		$584K Buy
+6,736
New +$631K 0.02% 468

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allstate Corporation's TECH Position: Q2 2026 in Review

Allstate Corporation increased its Bio-Techne (TECH) stake by 6% in Q2 2026, buying an estimated $21.2K and bringing the position to 6,947 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

Allstate Corporation first reported a position in TECH in Q2 2022 and has held it in 6 quarters since. The position peaked at $651K in Q4 2022. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Allstate Corporation held 6,947 shares of Bio-Techne worth $491K as of Q2 2026.
  • Allstate Corporation bought 393 Bio-Techne shares in Q2 2026, an estimated $21.2K.
  • Bio-Techne made up ﹤0.01% of Allstate Corporation's portfolio in Q2 2026, its #1042 holding.
  • Allstate Corporation first reported a position in Bio-Techne in Q2 2022 and has held it in 6 quarters since.
  • Allstate Corporation's Bio-Techne position peaked at $651K in Q4 2022.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.